Macau, China vs Sierra Leone: HIV-positive TB patients on ART (antiretroviral therapy)
Macau, China
100.0%
in 2024
Sierra Leone
100.0%
in 2024
Macau, China rank
1st
Sierra Leone rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Macau, China
- Sierra Leone
How they compare
Macau, China currently reports 100.0% against 100.0% in Sierra Leone, a difference of 0.0%.
The two have swapped places 3 times across 14 shared years of data; in 2010 it was Macau, China ahead.
Macau, China ranks 1st and Sierra Leone ranks 1st of 144 countries.
Sierra Leone has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Macau, China | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 65.3% | 66.6% | 1.2% | Sierra Leone |
| 2020s | 78.4% | 100.0% | 21.6% | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Macau, China or Sierra Leone?
- Macau, China, at 100.0% against 100.0% in Sierra Leone as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Macau, China and Sierra Leone?
- 0.0%, with Macau, China ahead.
- How many years of comparable data are there for Macau, China and Sierra Leone?
- 14 years are reported by both, from 2010 to 2024.
- How do Macau, China and Sierra Leone rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Macau, China ranks 1st and Sierra Leone ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.